Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$42,778,659
+$21,183,282 QoQ
Shares Held
1,387,566
+38.8% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 230 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. RCUS ranks #75 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in RCUS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,778,659 | 1,387,566 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $21,595,377 | 999,786 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $27,843,853 | 1,168,437 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $12,928,010 | 950,589 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,275,322 | 648,074 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,176,532 | 914,208 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $6,603,014 | 443,453 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $10,754,007 | 703,336 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $9,698,067 | 636,774 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,725,909 | 250,313 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $11,312,757 | 592,291 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $10,558,332 | 588,208 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $12,148,121 | 598,135 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $14,674,699 | 804,534 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $15,766,845 | 762,420 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $22,586,151 | 863,385 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $24,684,504 | 974,132 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $7,777,645 | 246,440 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,551,296 | 112,461 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $2,052,168 | 58,852 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $11,443,433 | 416,731 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $16,327,143 | 581,451 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $19,707,871 | 759,163 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,793,009 | 454,668 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $13,616,079 | 550,367 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,156,981 | 83,356 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||